Cargando…
Mefloquine Inhibits Esophageal Squamous Cell Carcinoma Tumor Growth by Inducing Mitochondrial Autophagy
Esophageal squamous cell carcinoma (ESCC) has a worldwide impact on human health, due to its high incidence and mortality. Therefore, identifying compounds to increase patients' survival rate is urgently needed. Mefloquine (MQ) is an FDA-approved anti-malarial drug, which has been reported to i...
Autores principales: | Xie, Yifei, Zhang, Jing, Lu, Bingbing, Bao, Zhuo, Zhao, Jimin, Lu, Xianyu, Wei, Yaxing, Yao, Ke, Jiang, Yanan, Yuan, Qiang, Zhang, Xiaofan, Li, Bo, Chen, Xinhuan, Dong, Zigang, Liu, Kangdong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400730/ https://www.ncbi.nlm.nih.gov/pubmed/32850358 http://dx.doi.org/10.3389/fonc.2020.01217 |
Ejemplares similares
-
Tegaserod Maleate Inhibits Esophageal Squamous Cell Carcinoma Proliferation by Suppressing the Peroxisome Pathway
por: Wu, Xiangyu, et al.
Publicado: (2021) -
Proteomics Reveal the Inhibitory Mechanism of Levodopa Against Esophageal Squamous Cell Carcinoma
por: Li, Zhenzhen, et al.
Publicado: (2020) -
Nuplazid suppresses esophageal squamous cell carcinoma growth in vitro and in vivo by targeting PAK4
por: Wei, Yaxing, et al.
Publicado: (2021) -
Dasabuvir suppresses esophageal squamous cell carcinoma growth in vitro and in vivo through targeting ROCK1
por: Liu, Xinning, et al.
Publicado: (2023) -
TOPK promotes metastasis of esophageal squamous cell carcinoma by activating the Src/GSK3β/STAT3 signaling pathway via γ-catenin
por: Jiang, Yanan, et al.
Publicado: (2019)